| Completed | LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) Covid-19, Lung Cancer | — | 2020-04-21 |
| Completed | Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC Lung Cancer | Phase 2 | 2018-07-15 |
| Completed | Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Non-small Cell Lung Cancer Stage IV | Phase 2 | 2018-07-07 |
| Terminated | Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS Non Small Cell Lung Cancer | Phase 2 | 2018-05-07 |
| Completed | T790M Mutation Testing in Blood by Different Methodologies NSCLC Stage IV | — | 2018-03-01 |
| Completed | Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient Non Small Cell Lung Cancer | — | 2017-06-01 |
| Completed | Durvalumab in HIV-1 Patients With Solid Tumors HIV, Cancer | Phase 2 | 2017-04-24 |
| Completed | Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients Non Small Cell Lung Cancer | Phase 2 | 2017-04-15 |
| Completed | Pembrolizumab in Elderly Patients With Advanced Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2017-01-15 |
| Completed | Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma Non-small Cell Lung Cancer | — | 2016-08-03 |
| Recruiting | Thoracic Tumours Register Thoracic Tumors | — | 2016-07-21 |
| Completed | Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC Lung Cancer | Phase 2 | 2016-04-15 |
| Completed | Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2011-08-01 |
| Completed | Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab Nonsquamous Nonsmall Cell Neoplasm of Lung | — | 2011-02-01 |
| Terminated | Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC Carcinoma, Non Small Cell Lung | Phase 2 | 2010-01-01 |
| Terminated | Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After E Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2008-05-01 |
| Terminated | Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma Non Small Cell Lung Cancer, BRCA1 Mutation | Phase 3 | 2008-02-01 |
| Completed | Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) Non-small-cell Lung Cancer | Phase 3 | 2007-06-01 |
| Completed | Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutat Non-Small Cell Lung Cancer | Phase 3 | 2007-02-15 |
| Completed | Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Non-small Cell Lung Cancer | N/A | 2005-06-01 |
| Completed | Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cel Non Small-cell Lung Cancer | Phase 2 | 2001-10-01 |
| Completed | Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer Non-Small-Cell Lung Cancer | Phase 3 | 1999-09-01 |